Electroacupuncture alleviates zymosan-induced colorectal hypersensitivity.

Researchers investigated whether electroacupuncture could help reduce abdominal pain and hypersensitivity in the colon and rectum, which are common symptoms of irritable bowel syndrome (IBS). Using a mouse model, scientists created colorectal hypersensitivity similar to what IBS patients experience and then treated the mice with repeated electroacupuncture sessions.

The study found that electroacupuncture significantly reduced colorectal sensitivity and pain responses. The researchers discovered that this pain relief occurred through changes in several pain-related proteins throughout the body. Specifically, electroacupuncture decreased the expression of proteins called TRPV1, nerve growth factor (NGF), substance P (SP), and protein kinase C gamma (PKCγ) in the colorectal tissue, spinal ganglia, and spinal cord—all areas involved in processing and transmitting pain signals.

Using advanced techniques including electrophysiology, Western blotting, and immunofluorescence staining, the team demonstrated that electroacupuncture works at a molecular level to interrupt pain pathways. The treatment appears to calm the hypersensitive state of the digestive tract by reducing the production of chemicals that amplify pain signals.

For IBS patients who suffer from chronic abdominal pain and discomfort, these findings suggest that electroacupuncture may offer a viable treatment option. The research provides scientific evidence for how this traditional therapy might work to relieve visceral pain. While this study was conducted in mice, the biological mechanisms are similar in humans, making the results promising for clinical application. If you're considering electroacupuncture for IBS symptoms, work with a qualified, licensed acupuncturist who has experience treating digestive disorders.

This preclinical study examined electroacupuncture's effect on zymosan-induced colorectal hypersensitivity in mice, an established IBS model. Researchers employed colorectal distension measurements, Western blotting, immunofluorescence staining, and electrophysiological techniques to assess treatment outcomes.

Repetitive electroacupuncture application significantly reduced colorectal sensitivity intensity. Mechanistically, EA suppressed expression of multiple pain-associated proteins: TRPV1, NGF in colorectal tissue, SP in dorsal root ganglia, and PKCγ in spinal cord. Immunofluorescence confirmed decreased expression across all measured tissues. Additionally, increased TRPV1/IB4 and TRPV1/NF200 double-positive neurons were observed in spinal ganglia, suggesting modulation of both nociceptive C-fibers and A-delta fibers.

Clinical implications: This study provides molecular evidence that EA modulates visceral pain through multi-level neural pathway regulation, from peripheral sensitization to central processing. The intervention targeted pain transmission at colorectal, DRG, and spinal cord levels. These findings support EA as a potential therapeutic intervention for IBS-related visceral hypersensitivity, offering practitioners evidence-based rationale for its clinical application in functional gastrointestinal disorders.